Drugmakers pause trials in Russia while still sending medicine
Major pharmaceutical firms are seeking to strike a balance between international opprobrium over Russia’s invasion of Ukraine and the needs of sick patients.
Japan to accept Johnson & Johnson COVID vaccine for border entry next month
The J&J shot, which has not been approved in Japan, will join a list of three other shots that have been approved by regulators as sufficient for nonresidents to enter.
Inside Johnson & Johnson’s secret plan to cap litigation payouts to cancer victims
If J&J succeeds, some experts argue, it could provide a blueprint for corporate America on how to circumvent jury trials involving allegations of defective products or misconduct.
Breakups usher in a new era of corporate conglomerates
Activists and corporate governance advocates cheered splits by GE, J&J and Toshiba, but tech firms have been driving unrelated transactions, creating what are called "neoconglomerates.”
South African study shows high protection from Johnson & Johnson shot
The country's health regulator approved the J&J shot in April, and it is being used in the national vaccine program alongside Pfizer's.
The company said that, once approval of its one-shot COVID-19 vaccine is given, it could begin supplying doses to the country in early 2022.
U.S. ends Johnson & Johnson COVID-19 vaccine pause, says shots to resume immediately
Officials found just 15 cases among the 8 million shots given that had experienced the syndrome involving severe blood clots and low platelets as a result of the vaccine.
Why the vaccine safety numbers are still fuzzy
If there is a connection between the Johnson & Johnson vaccine and a rare clotting syndrome, new cases are likely to emerge now that the word is out.
The FDA’s caution on the J&J vaccine is a costly mistake
The FDA acted after blood clots were observed in less than one in a million people who have received the J&J vaccine. COVID-19 has already killed 1,712 out of every million Americans.
Vaccine blood-clot side effect puts focus on immune reaction
Health officials are exploring whether and how an immune reaction may occur in people who have received vaccines made by AstraZeneca and Johnson & Johnson.
U.S. calls for pause on Johnson & Johnson vaccine after clotting cases
The concerns about the shot mirror those about AstraZeneca’s, which European regulators began investigating last month after some recipients developed blood clots.
